First blood test for osteoarthritis could soon be available ~ hiv virus

The first blood test for osteoarthritis could soon be developed, thanks to research by the University of Warwick.

The research findings could potentially lead to patients being tested for osteoarthritis and diagnosed several years before the onset of physical symptoms.

Conducted by the University's Medical School, the research identified a biomarker linked to both rheumatoid and osteoarthritis.

Whilst there are established tests for rheumatoid arthritis (RA), the newly identified biomarker could lead to one which can diagnose both rheumatoid arthritis and osteoarthritis (OA).

The research's focus was citrullinated proteins (CPs), a biomarker suspected to be present in blood of people with early stage rheumatoid arthritis. It had previously been established that patients with RA have antibodies to CPs, but it was not thought that this was the same for those with OA.

However, the Warwick researchers found for the first time increased CPs levels in both early-stage OA and RA.

They then produced an algorithm of three biomarkers, CPs, anti-CP antibodies along with, the bone-derived substance, hydroxyproline.

Using the algorithm the researchers found that with a single test they could potentially detect and discriminate between the major types of arthritis at the early stages, before joint damage has occurred.

Commenting on the findings, lead researcher, Dr Naila Rabbani said:

"This is a remarkable and unexpected finding. It could help bring early-stage and appropriate treatment for arthritis which gives the best chance of effective treatment".

Explaining the role of CPs in relation to both RA and OA and the importance of the algorithm to the research Dr Rabbani said:

"It has been long established that the autoimmunity of early-stage RA leads to antibodies to CPs, but the autoimmunity, and hence antibodies, are absent in early-stage OA. Using this knowledge and applying the algorithm of biomarkers we developed provides the basis to discriminate between these two major types of arthritis at an early stage".

The ability to discriminate between RA and OA could provide a number of benefits to patients, including early diagnosis. Dr Rabbani said:

"Detection of early stage-OA made the study very promising and we would have been satisfied with this only – but beyond this we also found we could detect and discriminate early-stage RA and other inflammatory joint diseases at the same.

"This discovery raises the potential of a blood test that can help diagnose both RA and OA several years before the onset of physical symptoms".

The research, Biomarkers of early stage osteoarthritis, rheumatoid arthritis and musculoskeletal health, is published by Nature Scientific Reports.

Explore further: Inflammation in the mouth and joints in rheumatoid arthritis

Medical Xpress on facebook

Recommended for you

World Trade Center workers at increased risk of developing autoimmune diseases

Mar 16, 2015

A new study has found a strong link between prolonged work at the World Trade Center (WTC) site following the terrorist attacks of September 11, 2001 and the development of various autoimmune diseases including arthritis ...

Mothers help young people with arthritis through the tough times

Mar 16, 2015

Young people with arthritis rely heavily on their mums for support during times of change and uncertainty – despite claiming to be independent, according to new research from Arthritis Research UK.

Long-term NSAID use beneficial in knee osteoarthritis

Mar 12, 2015

(HealthDay)—For patients with knee osteoarthritis, long-term nonsteroidal anti-inflammatory drug (NSAID) use is associated with improvements in symptoms and disease progression, according to a study published ...

Inflammation in the mouth and joints in rheumatoid arthritis

Mar 12, 2015

Guidelines provided for viscosupplementation in knee OA

Mar 12, 2015

(HealthDay)—For patients with knee osteoarthritis, the evidence should be considered before recommending viscosupplementation, according to a case vignette study published in the March 12 issue of the New En ...

M-MDSCs shut down arthritis in mouse model of the disease

Mar 06, 2015

Using a mouse model of rheumatoid arthritis, scientists have discovered that a form of cellular immunotherapy by intravenous administration of monocytic myeloid-derived suppressor cells, or M-MDSCs, might be an effective ...

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.

Sign in to get notified via email when new comments are made.

Disclaimer

Home

Arthritis & Rheumatism

March 20, 2015